GHK-Cu 50 mg, BPC-157 10 mg, TB-500 (TB4) 10 mg & KPV 10 mg
KLOW 80 mg is a four-peptide research formulation composed of GHK-Cu, BPC-157, TB-500 (TB4), and KPV in a lyophilized powder format intended exclusively for laboratory and analytical applications.
This blend is designed as a multi-component research model combining four peptides that are individually studied in distinct biological and biochemical pathways. Together, they provide a consolidated format for investigating multi-pathway peptide interactions within controlled laboratory environments.
The four components are commonly categorized in research literature as follows:
- GHK-Cu: copper-binding peptide studied in collagen and extracellular matrix signaling models
- BPC-157: peptide investigated in vascular and cellular signaling research models
- TB-500 (TB4): Naturally occurring peptide studied in cell migration, actin regulation, and related biological pathways.
- KPV: tripeptide fragment derived from alpha-MSH studied in inflammatory signaling pathway research
In combination, KLOW is utilized in research contexts exploring overlapping mechanisms such as cellular signaling, peptide stability interactions, and multi-pathway biochemical modeling in vitro.
Manufactured using peptide synthesis and purification processes, KLOW is supplied as a stable lyophilized powder to support storage stability and controlled laboratory handling.